Monoclonal antibodies for the treatment of COVID‐19 in a patient with high‐risk acute leukaemia

Paul Saultier (1) , Laetitia Ninove (2) , Sarah Szepetowski , Mathilde Veneziano , Sandrine Visentin , Vincent Barlogis , Paola Mariela Saba Villarroel , Abdennour Amroun , Marie Loosveld , Xavier de Lamballerie (2) , Hervé Chambost (1)

1 C2VN - Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research
2 UVE - Unité des Virus Emergents

Mots clés: hematologic neoplasms; COVID-19; SARS-CoV-2; COVID-19 drug treatment; monoclonal antibodies

Domaines: Sciences du Vivant [q-bio]

Paul Saultier, Laetitia Ninove, Sarah Szepetowski, Mathilde Veneziano, Sandrine Visentin, et al.. Monoclonal antibodies for the treatment of COVID‐19 in a patient with high‐risk acute leukaemia. British Journal of Haematology, 2022, 196 (1), pp.E1-E3. ⟨10.1111/bjh.17756⟩. ⟨hal-03813942⟩